LEDGF/p75 interacts with mRNA splicing factors and targets HIV-1 integration to highly spliced genes

The host chromatin-binding factor LEDGF/p75 interacts with HIV-1 integrase and directs integration to active transcription units. To understand how LEDGF/p75 recognizes transcription units, we sequenced 1 million HIV-1 integration sites isolated from cultured HEK293T cells. Analysis of integration sites showed that cancer genes were preferentially targeted, raising concerns about using lentivirus vectors for gene therapy. Additional analysis led to the discovery that introns and alternative splicing contributed significantly to integration site selection. These correlations were independent of transcription levels, size of transcription units, and length of the introns. Multivariate analysis with five parameters previously found to predict integration sites showed that intron density is the strongest predictor of integration density in transcription units. Analysis of previously published HIV-1 integration site data showed that integration density in transcription units in mouse embryonic fibroblasts also correlated strongly with intron number, and this correlation was absent in cells lacking LEDGF. Affinity purification showed that LEDGF/p75 is associated with a number of splicing factors, and RNA sequencing (RNA-seq) analysis of HEK293T cells lacking LEDGF/p75 or the LEDGF/p75 integrase-binding domain (IBD) showed that LEDGF/p75 contributes to splicing patterns in half of the transcription units that have alternative isoforms. Thus, LEDGF/p75 interacts with splicing factors, contributes to exon choice, and directs HIV-1 integration to transcription units that are highly spliced.

[1]  F. Bushman,et al.  HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. , 2007, Genome research.

[2]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[3]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[4]  A. Kornblihtt,et al.  Multiple links between transcription and splicing. , 2004, RNA.

[5]  Florian Klein,et al.  HIV-1 Integration Landscape during Latent and Active Infection , 2015, Cell.

[6]  Paul Shinn,et al.  A role for LEDGF/p75 in targeting HIV DNA integration , 2005, Nature Medicine.

[7]  Goedele N. Maertens,et al.  The mechanism of retroviral integration through X-ray structures of its key intermediates , 2010, Nature.

[8]  S. Hughes,et al.  Specific HIV integration sites are linked to clonal expansion and persistence of infected cells , 2014, Science.

[9]  Nevan J Krogan,et al.  Adventures in time and space , 2014, RNA biology.

[10]  A. Engelman,et al.  HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor , 2012, Nucleic acids research.

[11]  S. Ekker,et al.  TALEN Knockout of the PSIP1 Gene in Human Cells: Analyses of HIV-1 Replication and Allosteric Integrase Inhibitor Mechanism , 2014, Journal of Virology.

[12]  Y. Jacob,et al.  TOX4 and NOVA1 Proteins Are Partners of the LEDGF PWWP Domain and Affect HIV-1 Replication , 2013, PloS one.

[13]  A. Schambach,et al.  Bromo- and Extraterminal Domain Chromatin Regulators Serve as Cofactors for Murine Leukemia Virus Integration , 2013, Journal of Virology.

[14]  Kenneth A. Matreyek,et al.  Differential Effects of Human Immunodeficiency Virus Type 1 Capsid and Cellular Factors Nucleoporin 153 and LEDGF/p75 on the Efficiency and Specificity of Viral DNA Integration , 2012, Journal of Virology.

[15]  Brendan B. Larsen,et al.  Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection , 2014, Science.

[16]  A. Kornblihtt,et al.  Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. , 1999, Molecular cell.

[17]  A. Kornblihtt,et al.  The carboxy terminal domain of RNA polymerase II and alternative splicing. , 2010, Trends in biochemical sciences.

[18]  X. Darzacq,et al.  The In Vivo Kinetics of RNA Polymerase II Elongation during Co-Transcriptional Splicing , 2011, PLoS biology.

[19]  Andreas D. Baxevanis,et al.  MLV integration site selection is driven by strong enhancers and active promoters , 2014, Nucleic acids research.

[20]  Jernej Ule,et al.  Psip1/Ledgf p52 Binds Methylated Histone H3K36 and Splicing Factors and Contributes to the Regulation of Alternative Splicing , 2012, PLoS genetics.

[21]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[22]  Harold E. Varmus,et al.  Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection , 1992, Cell.

[23]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[24]  A. Engelman,et al.  LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. , 2007, Genes & development.

[25]  F. Bushman,et al.  Role of the PWWP Domain of Lens Epithelium-derived Growth Factor (LEDGF)/p75 Cofactor in Lentiviral Integration Targeting* , 2011, The Journal of Biological Chemistry.

[26]  Michael Poidinger,et al.  Enhancers Are Major Targets for Murine Leukemia Virus Vector Integration , 2014, Journal of Virology.

[27]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[28]  Sridhar Hannenhalli,et al.  Selection of Target Sites for Mobile DNA Integration in the Human Genome , 2006, PLoS Comput. Biol..

[29]  J. Manley,et al.  The RNA polymerase C-terminal domain , 2011, Transcription.

[30]  Pamela A. Silver,et al.  Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase* , 2004, Journal of Biological Chemistry.

[31]  R. Gorelick,et al.  Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes , 2013, Nucleic acids research.

[32]  F. Bushman,et al.  The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. , 2013, Cell reports.

[33]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[34]  A. Kornblihtt,et al.  A slow RNA polymerase II affects alternative splicing in vivo. , 2003, Molecular cell.

[35]  C. Van den Haute,et al.  Transient and Stable Knockdown of the Integrase Cofactor LEDGF/p75 Reveals Its Role in the Replication Cycle of Human Immunodeficiency Virus , 2006, Journal of Virology.

[36]  F. Bushman,et al.  BET proteins promote efficient murine leukemia virus integration at transcription start sites , 2013, Proceedings of the National Academy of Sciences.

[37]  A. Engelman,et al.  Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Frederic D. Bushman,et al.  Efficacy of gene therapy for X-linked severe combined immunodeficiency. , 2010, The New England journal of medicine.

[39]  M. Llano,et al.  LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes , 2004, Journal of Virology.

[40]  A. Schambach,et al.  Gene therapy on the move , 2013, EMBO molecular medicine.

[41]  Robert Craigie,et al.  HIV DNA integration. , 2012, Cold Spring Harbor perspectives in medicine.

[42]  A. Wolffe,et al.  A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. , 1998, Molecular cell.

[43]  Wulin Teo,et al.  An Essential Role for LEDGF/p75 in HIV Integration , 2006, Science.

[44]  E. Wang,et al.  Analysis and design of RNA sequencing experiments for identifying isoform regulation , 2010, Nature Methods.

[45]  R. Benarous,et al.  The Interaction of LEDGF/p75 with Integrase Is Lentivirus-specific and Promotes DNA Binding* , 2005, Journal of Biological Chemistry.

[46]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[47]  A. Engelman,et al.  Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration , 2010, Proceedings of the National Academy of Sciences.

[48]  A. Engelman,et al.  A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo , 2006, Nucleic acids research.

[49]  Zeger Debyser,et al.  LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  K. Neugebauer,et al.  Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells , 2006, Nature Structural &Molecular Biology.

[51]  Zeger Debyser,et al.  HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells* , 2003, The Journal of Biological Chemistry.

[52]  E. De Clercq,et al.  LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells* , 2003, Journal of Biological Chemistry.

[53]  M. Llano,et al.  Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75. , 2006, Journal of molecular biology.

[54]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[55]  M. Llano,et al.  LEDGF/p75 Proteins with Alternative Chromatin Tethers Are Functional HIV-1 Cofactors , 2009, PLoS pathogens.

[56]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.